InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.435
+0.015 (0.62%)
At close: Oct 8, 2025, 4:00 PM EDT
2.440
+0.005 (0.21%)
After-hours: Oct 8, 2025, 6:06 PM EDT
InspireMD Market Cap
InspireMD has a market cap or net worth of $101.59 million as of October 8, 2025. Its market cap has increased by 43.08% in one year.
Market Cap
101.59M
Enterprise Value
85.64M
1-Year Change
43.08%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since April 12, 2011, InspireMD's market cap has increased from $54.90M to $101.59M, an increase of 85.05%. That is a compound annual growth rate of 4.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 101.60M | 48.10% |
Dec 31, 2024 | 68.60M | 13.20% |
Dec 29, 2023 | 60.60M | 741.67% |
Dec 30, 2022 | 7.20M | -70.49% |
Dec 31, 2021 | 24.40M | 93.65% |
Dec 31, 2020 | 12.60M | 223.08% |
Dec 31, 2019 | 3.90M | -35.00% |
Dec 31, 2018 | 6.00M | 500.00% |
Dec 29, 2017 | 1.00M | -72.22% |
Dec 30, 2016 | 3.60M | -47.83% |
Dec 31, 2015 | 6.90M | -77.45% |
Dec 31, 2014 | 30.60M | -62.08% |
Dec 31, 2013 | 80.70M | 5.08% |
Dec 31, 2012 | 76.80M | -32.93% |
Dec 30, 2011 | 114.50M | 108.56% |
Apr 12, 2011 | 54.90M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 766.26B |
Johnson & Johnson | 454.28B |
AbbVie | 407.00B |
UnitedHealth Group | 334.53B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 231.62B |